Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Sort descending Drug Company PI Date Risk List Available?
Intralipid Fresenius Kabi Limited April 2016
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Isoniazid Sandoz Inc. October 2018
Isoniazid Macleods Pharmaceuticals September 2011
Lamivudine (Epivir) - New GlaxoSmithKline May 2019 YES
Lamivudine/Zidovudine (Combivir) GlaxoSmithKline April 2018 YES
Ledipasvir/Sofosbuvir (Harvoni) Gilead November 2017
Levonorgestrel Northstar Rx April 2018
Lopinavir/Ritonavir (Kaletra) AbbVie November 2018 YES
Losartan Potassium (Cozaar) Merck October 2018
Maraviroc (Selzentry) ViiV Healthcare July 2018 YES
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Nevirapine (Viramune) Boehringer Ingelhiem Pharmaceuticals September 2018 YES
Paclitaxel Accord Healthcare Limited       January 2018
Peginterferon alfa 2b (Pegintron) Merck January 2019
Pitavastatin (Livalo)         Kowa November 2016
Pravastatin Sandoz December 2006
Raltegravir (Isentress) Merck January 2019 YES
Ribavirin - New Aurobindo Pharma Limited October 2018
Rifabutin Greenstone LLC April 2018


No records to display.